DrugPatentWatch Database Preview
Profile for Canada Patent: 2699986
US Patent Family Members and Approved Drugs for Canada Patent: 2699986
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
➤ Sign Up | Sep 17, 2028 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | Sep 17, 2028 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | May 17, 2029 | Abbvie Inc | VIEKIRA XR | dasabuvir sodium; ombitasvir; paritaprevir; ritonavir |
➤ Sign Up | May 17, 2029 | Abbvie Inc | VIEKIRA PAK (COPACKAGED) | dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir |
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |